5AM Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
22
- Investments
-
209
- Portfolio
-
42
- Exits
-
74
5AM Ventures General Information
Description
Founded in 2002, 5AM Ventures is a venture capital firm based in San Francisco, California. The firm seeks to invest in advanced life science technologies, biopharmaceutical, drug delivery technology and research instrument sectors.
Contact Information
Website
www.5amventures.com
Year Founded
2002
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Primary Office
- 501 Second Street
- Suite 350
- San Francisco, CA 94107
- United States
+1 (415) 000-0000
5AM Ventures Investments (209)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Magnetic Insight | 23-Jun-2022 | Later Stage VC | 0000 | Diagnostic Equipment | Generating Revenue | 00000 0000000 00.0 |
| 0000 | 13-May-2022 | 00000 00000 | 00000 | Other Healthcare Technology Systems | Generating Revenue | 000000 000000 |
| 00000000 000000000 | 19-Apr-2022 | 00000 00000 | 00000 | Biotechnology | Pre-Clinical Trials | |
| 0000000 0000000000 | 19-Jan-2022 | 00000 00000 | 000.00 | Drug Discovery | Startup | 000000 000000 |
| 0000 000000000000 | 03-Dec-2021 | 0000 | 00000 | Other Healthcare Technology Systems | Generating Revenue/Not Profitable | 000000 000000 |
| 00000000 | 05-Nov-2021 | 00000 00000 | 000.00 | Other Healthcare Technology Systems | Generating Revenue | 0000 00000000000 00.0 |
| 00000000000 000000 | 18-Oct-2021 | 00000 00000 | 0000 | Drug Discovery | Startup | 00000 0000000 00.0 |
| 000000000 00000000 | 29-Sep-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
| CinCor Pharma | 22-Sep-2021 | Early Stage VC | 00000 | Drug Discovery | Generating Revenue/Not Profitable | 00000 0000000 00.0 |
| RareCyte | 09-Sep-2021 | Later Stage VC | 0000 | Diagnostic Equipment | Generating Revenue | 000000 000000 |
5AM Ventures Exits (74)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| CinCor Pharma | 07-Jan-2022 | IPO | 00000 |
| 0000 000000000000 | 03-Dec-2021 | 0000000 000000 | 00000 |
| 0000000 0000000000 | 02-Nov-2021 | 000 | 00000 |
| 00000 00000000000 | 10-Sep-2021 | 000000 0000000000 | 0000 |
| 00000000 | 29-Jul-2021 | 000 | 000.00 |
| 000000000 00000000 | 01-Jun-2021 | 000000000000000000 | |
| 00000 00000000000 | 22-Apr-2021 | 000 | 0000 |
| 000 000000000 | 05-Feb-2021 | 000 | 00000 |
| Chrono Therapeutics | 01-Feb-2021 | Out of Business | |
| 5:01 Acquisition | 14-Oct-2020 | IPO | 0000 |
5AM Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
5AM Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
5AM Ventures Team (71)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Rebecca Lucia | Chief Financial Officer, Chief Operating Officer and Partner | San Francisco, CA | |||
| Andrew Schwab | Co-Founder & Managing Partner | 00 | 0 | 00 | San Francisco, CA |
| John Diekman Ph.D | Co-Founding Partner | 00 | 0 | 0 | San Francisco, CA |
| Scott Rocklage Ph.D | Co-Founding Partner | 00 | 0 | 0 | Boston, MA |
| James Young Ph.D | Venture Partner | 0 | 0 | 0 | San Francisco, CA |
5AM Ventures Co-Investors (191)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 9 | 0 | 0 |
|
|
| Roche Venture Fund | 0 | 00 |
|
|
|
| OrbiMed | 0 | 00 |
|
|
|
| RA Capital Management | 0 | 0 |
|
|
|
| Cormorant Asset Management | 0 | 0 |
|
|